Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK

被引：20

作者：

Alfageh, Basmah H. ^{[1
,2
]}

Man, Kenneth K. C. ^{[1
,3
,4
]}

Besag, Frank M. C. ^{[1
,5
,6
,7
]}

Alhawassi, Tariq M. ^{[2
]}

Wong, Ian C. K. ^{[1
,3
]}

Brauer, Ruth ^{[1
]}

机构：

[1] UCL, Sch Pharm, Res Dept Practice & Policy, London, England

[2] King Saud Univ, Coll Pharm, Riyadh, Saudi Arabia

[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res,Pokfulam, Hong Kong, Peoples R China

[4] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands

[5] East London Fdn NHS Trust, London, Beds, England

[6] Kings Coll London, Maudsley Hosp, London, England

[7] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England

来源：

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS | 2020年 / 50卷 / 02期

关键词：

Autism spectrum disorder; Psychotropic medication; Prevalence; Incidence; CHILDREN; PEOPLE; ADOLESCENTS;

D O I：

10.1007/s10803-019-04291-8

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

Autism spectrum disorder (ASD) is a lifelong disorder. In the UK, risperidone is the only psychotropic medication approved for the management of the behavioural symptoms that may accompany autism. This is a population-based study aimed to provide an evaluation of the changing trend in the incidence and prevalence of ASD and to analyse the pattern of psychotropic medication prescribing in the UK. 20,194 patients with ASD were identified. The prevalence increased 3.3-fold from 0.109 per 100 persons in 2009 to 0.355 per 100 persons in 2016. Approximately one-third of the identified cohort was prescribed at least one psychotropic medication. Although the medications approved to manage the symptoms of ASD are limited, the prescribing of such medications is increasing.

引用

页码：625 / 633

页数：9

共 28 条

[1]

[Anonymous], 2013, AUT SPECTR DIS 19 S

[2]

[Anonymous], ADHD INCIDENCE TREAT

[3]

[Anonymous], 2015, THIN DAT GUID RES

[4]

[Anonymous], 2013, APPL INCL 19 EXP COM

[5]

[Anonymous], 2009, Annual Information Form

[6]

[Anonymous], 2013, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425596.744053

[7] Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study [J].

Barnett, Karen ;

Mercer, Stewart W. ;

Norbury, Michael ;

Watt, Graham ;

Wyke, Sally ;

Guthrie, Bruce .

LANCET, 2012, 380 (9836) :37-43

[8]

Blak Betina T, 2011, Inform Prim Care, V19, P251

[9]

Carey IM, 2017, HSDR, V5, DOI [DOI 10.3310/HSDR05250, 10.3310/hsdr05250]

[10] Autism and sleep disorders [J].

Devnani, Preeti A. ;

Hegde, Anaita U. .

JOURNAL OF PEDIATRIC NEUROSCIENCES, 2015, 10 (04) :304-307

← 1 2 3 →